NCT03389412View on ClinicalTrials.gov

The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.

PHASE4CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

January 3, 2023

Study Completion Date

January 3, 2023

Conditions
Enuresis, Nocturnal
Interventions
DRUG

Desmopressin

The children will be treated with 120 microgram/day the first two weeks. If the child is not completely dry, the dose will be increased to 240 microgram/day the rest of the study period (maximum eight weeks of treatment).

DEVICE

Conditional alarm

Eight weeks of treatment.

Trial Locations (6)

8000

Algemeen Ziekenhuis Sint-Jan Brugge, Bruges

8200

Aarhus University Hospital, Aarhus

9000

Ghent University Hospital, Ghent

Aalborg University Hospital, Aalborg

Unknown

First Affiliated Hospital of Zhengzhou University, Zhengzhou

80-952

University Clinical Centre in Gdańsk, Gdansk

All Listed Sponsors
collaborator

University Ghent

OTHER

collaborator

First Affiliated Hospital of Zhengzhou University, China

UNKNOWN

collaborator

University Clinical Centre in Gdansk, Poland

UNKNOWN

lead

University of Aarhus

OTHER

NCT03389412 - The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings. | Biotech Hunter | Biotech Hunter